The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: An exploratory subgroup analysis of JCOG1113.

被引：0
|
作者：
Yamada, Ikuhiro
Morizane, Chigusa
Okusaka, Takuji
Ogawa, Gakuto
Sato, Yuya
Ueno, Makoto
Ikeda, Masafumi
Sugimori, Kazuya
Fukutomi, Akira
Shimizu, Satoshi
Mizuno, Nobumasa
Yanagimoto, Hiroaki
Sano, Keiji
Tobimatsu, Kazutoshi
Yane, Kei
Nakamori, Shoji
Sata, Naohiro
Nishina, Tomohiro
Ishii, Hiroshi
Furuse, Junji
机构：
[1] Japanese Fdn Canc Res, Tokyo, Japan
[2] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[3] Natl Canc Ctr, Tokyo, Japan
[4] Natl Canc Ctr, Ctr Res Adm & Support, Tokyo, Japan
[5] Natl Canc Ctr, Japan Clin Oncol Grp, Data Ctr, Operat Off, Tokyo, Japan
[6] Kanagawa Canc Ctr, Hepatobiliary & Pancreat Med Oncol Div, Dept Gastroenterol, Yokohama, Kanagawa, Japan
[7] Natl Canc Ctr Hosp East, Chiba, Japan
[8] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa, Japan
[9] Shizuoka Prefectural Gen Hosp, Canc Ctr, Shizuoka, Japan
[10] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan
[11] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan
[12] Kansai Med Univ, Osaka, Japan
[13] Teikyo Univ, Sch Med, Tokyo, Japan
[14] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan
[15] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan
[16] Natl Hosp Org Osaka Natl Hosp, Dept Hepatobiliary Pancreat Surg, Osaka, Japan
[17] Jichi Med Univ, Shimotsuke, Tochigi, Japan
[18] Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[19] Chiba Canc Ctr, Clin Res Ctr, Chiba, Japan
[20] Kyorin Univ, Fac Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
349
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combination therapy with capecitabine and cisplatin as second-line chemotherapy for advanced biliary tract cancer
    Jung, Jang Han
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    Park, Jeong Youp
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 210 - 210
  • [42] Cost-effectiveness analysis of pembrolizumab in combination with chemotherapy compared with chemotherapy alone as first-line treatment for patients with advanced biliary tract cancer in China
    Zheng, Zhiwei
    Fang, Ling
    Cai, Hongfu
    BMC CANCER, 2023, 23 (01)
  • [43] Cost-effectiveness analysis of pembrolizumab in combination with chemotherapy compared with chemotherapy alone as first-line treatment for patients with advanced biliary tract cancer in China
    Zhiwei Zheng
    Ling Fang
    Hongfu Cai
    BMC Cancer, 23
  • [44] Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Di Federico, Alessandro
    Palloni, Andrea
    Carloni, Riccardo
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    Messina, Carlo
    Spallanzani, Andrea
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    MEDICINA-LITHUANIA, 2022, 58 (11):
  • [45] Clinical outcomes of gemcitabine, cisplatin plus S-1 in patients with advanced biliary tract cancer
    Niisato, Yusuke
    Ishida, Hiroyasu
    Onoda, Tsubasa
    Shimoyamada, Yudai
    Ito, Yuka
    Yamaguchi, Takashi
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Hirofumi Kogure
    Osamu Togawa
    Nobuo Toda
    Ichiro Yasuda
    Osamu Hasebe
    Iruru Maetani
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Minoru Tada
    Masao Omata
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
  • [47] Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
    Watanabe, Akinori
    Kida, Mitsuhiro
    Miyazawa, Shiro
    Iwai, Tomohisa
    Okuwaki, Kosuke
    Kaneko, Toru
    Yamauchi, Hiroshi
    Takezawa, Miyoko
    Imaizumi, Hiroshi
    Koizumi, Wasaburo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (19) : 5979 - 5984
  • [48] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Toda, Nobuo
    Yasuda, Ichiro
    Hasebe, Osamu
    Maetani, Iruru
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1101 - 1107
  • [49] Benefit of second-line chemotherapy in patients with advanced biliary tract cancer: A propensity score analysis
    Thanasombunsukh, Kijjakom
    Khorana, Jiraporn
    Tantraworasin, Apichat
    Charoentum, Chaiyut
    ANNALS OF ONCOLOGY, 2022, 33 : S496 - S496
  • [50] Survival outcomes with observation or adjuvant therapy in elderly patients with biliary tract cancer
    Gbolahan, Olumide B.
    Zhi, Xiaojie
    Botrus, Gehan
    Shah, Mihir Maheshkumar
    Sarmiento, Juan
    Russell, Maria C.
    Kooby, David A.
    Maithel, Shishir K.
    Alese, Olatunji B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345